Category Archives: Research and Development

START findings highlight treatment divide

By on .

“It’s just more scientific evidence to back what we’ve been saying for a long time.” Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, announcing the conclusion of the START trial, which began in 2011 to assess “the best time for healthy HIV-infected people to begin antiretrovirals.” The announcement from the National Institute […]

AIDS vaccine update: With Thai trial, broadly neutralizing antibodies, new technologies and monkeys that met the SIV challenge, “we’re closer than ever”

By on .

NIH AIDS Vaccine Research Program Director: “The future of HIV-1 Vaccines is bright.” In 1997, scientists announced the birth of Dolly the cloned sheep, a computer named Deep Blue beat reigning chess champion Gary Kasparov, and the Hubble telescope brought the far reaches of outer space closer. President Bill Clinton pointed to all of these […]

Fauci: HIV imaging yields “significant advance” in vaccine inquiry

By on .

For 15 years scientists have worked to get a clear enough picture of how the protein surrounding the virus that leads to AIDS interacts with antibodies, to guide the development of a vaccine that would instigate an effective immune response. For years, the delicate and complicated structure of that protein has made that difficult, and […]

Study yields clues on HIV strains with “evolutionary advantage” that can guide vaccine development

By on .

While the virus that leads to AIDS has long been recognized to be “sloppy” in its replication, changing over time into divergent strains,  a National Institutes of Health-funded study recently found the virus that a person transmits tends to continue to look like the virus that originally infected that person. The study, significant for the […]